Nanoencorafenib
/ Nanoform
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 14, 2025
NANOFORM OUTLICENSES NANOENCORAFENIB AND SIGNS DEVELOPMENT AND COMMERCIALISATION AGREEMENT WITH A.FORALL AND IMGA
(TradingView)
- "The signing of a Letter of Intent with respect to BRAFMed Lda was first announced by Nanoform on May 20th, 2025."
Licensing / partnership • Oncology
1 to 1
Of
1
Go to page
1